CA Stock MarketDetailed Quotes
HBP Helix BioPharma Corp
- 0.930
- -0.070-7.00%
15min DelayTrading Dec 19 10:37 ET
45.59MMarket Cap-0.89P/E (TTM)
0.930High0.870Low2.22KVolume0.880Open1.000Pre Close1.96KTurnover1.35052wk High0.01%Turnover Ratio49.02MShares0.50052wk Low-1.05EPS TTM40.96MFloat Cap40.250Historical HighLossP/E (Static)44.04MShs Float0.300Historical Low-1.05EPS LYR6.00%Amplitude--Dividend TTM-465.00P/B1Lot Size--Div YieldTTM
About Helix BioPharma Corp Company
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.
Company Profile
SymbolHBP
Company NameHelix BioPharma Corp
Founded1995
MarketTSE
Employees7
Fiscal Year Ends07-31
Address40 Temperance Street Suite 2700, Bay Adelaide Centre - North Tower
CityToronto
CountryCAN
Zip CodeM5H0B4
Phone+1 604 684-2181
Company Executives
- Name
- Position
- Salary
- Jacek Antas
- Director and Chief Executive Officer
- --
- Dr. Srikanth Sola
- Chief Strategy Officer and Interim Chief Medical Officer
- --
- Christof Boehler
- Chief Business Development Officer
- --
- Praveen K. Varshney, C.F.A.,F.C.A.
- Chief Financial Officer and Corporate Secretary
- --
- Jerzy Leszczynski
- Independent Director
- --
- Janusz Grabski
- Independent Director
- --
- Malgorzata Laube
- Independent Director
- --
Heat List
CA
Overall
Symbol
Price
% Chg
No Data